FRA:GU5's Forward Dividend Yield % is ranked better than 64.71% of 68
companies
in the Medical Distribution industry
Industry Median: 2.96
vs FRA:GU5: 6.79
During the past 12 months, Guangzhou Baiyunshan Pharmaceutical Holdings Co's average Dividends Per Share Growth Rate was -30.40% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was 5.20% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was 11.70% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Guangzhou Baiyunshan Pharmaceutical Holdings Co was 70.50% per year. The lowest was -26.10% per year. And the median was 11.90% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Guangzhou Baiyunshan Pharmaceutical Holdings Co Forward Dividend Yield % Related Terms
FRA:GU5 vs MCK, CAH, COR: Forward Dividend Yield % Comparison
For the Medical Distribution subindustry, Guangzhou Baiyunshan Pharmaceutical Holdings Co's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Guangzhou Baiyunshan Pharmaceutical Holdings Co Forward Dividend Yield % vs Medical Distribution Industry
Guangzhou Baiyunshan Pharmaceutical Holdings Co Forward Dividend Yield % Calculation
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
Guangzhou Baiyunshan Pharmaceutical Holdings Co Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
HKD 0.516200
2026-06-12
2026-06-16
2026-07-17
Cash Dividend
semi-annually
HKD:EUR 0.109231
HKD 0.439900
2025-08-29
2025-09-02
2025-09-26
Cash Dividend
semi-annually
HKD:EUR 0.110204
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Forward Dividend Yield % of 6.79% mean?
Guangzhou Baiyunshan Pharmaceutical Holdings Co (FRA:GU5) has a Forward Dividend Yield % of 6.79% as of Jun. 29, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Guangzhou Baiyunshan Pharmaceutical Holdings Co and its competitors. According to the industry distribution chart, Guangzhou Baiyunshan Pharmaceutical Holdings Co ranks #24 out of 68 companies in the Medical Distribution industry, placing it in the top 35.3%.
Is Guangzhou Baiyunshan Pharmaceutical Holdings Co's Forward Dividend Yield % too high?
Guangzhou Baiyunshan Pharmaceutical Holdings Co's current Forward Dividend Yield % is 6.79%. The Medical Distribution industry median Forward Dividend Yield % is 2.96. Guangzhou Baiyunshan Pharmaceutical Holdings Co's value of 6.79% is 129.4% above this industry median. Based on the distribution chart, Guangzhou Baiyunshan Pharmaceutical Holdings Co ranks #24 out of 68 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Guangzhou Baiyunshan Pharmaceutical Holdings Co has a GF Score™ of 71/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Guangzhou Baiyunshan Pharmaceutical Holdings Co's Forward Dividend Yield % compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Guangzhou Baiyunshan Pharmaceutical Holdings Co ranks #24 out of 68 companies for Forward Dividend Yield %. This puts Guangzhou Baiyunshan Pharmaceutical Holdings Co in the upper half of its industry. The industry median Forward Dividend Yield % is 2.96. Guangzhou Baiyunshan Pharmaceutical Holdings Co's value of 6.79% is 129.4% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Medical Distribution company?
The median Forward Dividend Yield % among Medical Distribution companies is 2.96, based on 68 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Guangzhou Baiyunshan Pharmaceutical Holdings Co's current Forward Dividend Yield % of 6.79% is 129.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Guangzhou Baiyunshan Pharmaceutical Holdings Co and its competitors. For the Medical Distribution industry, the median Forward Dividend Yield % is 2.96 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Guangzhou Baiyunshan Pharmaceutical Holdings Co's current Forward Dividend Yield % is 6.79%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guangzhou Baiyunshan Pharmaceutical Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Guangzhou Baiyunshan Pharmaceutical Holdings Co (FRA:GU5) is currently considered Significantly Undervalued. The stock's GF Value™ is €2.30, compared to a current price of €1.55 — trading 32.6% below its estimated fair value. The current Forward Dividend Yield % is 6.79% and 129.4% above the Medical Distribution industry median of 2.96. Guangzhou Baiyunshan Pharmaceutical Holdings Co's overall GF Score™ is 71/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For Guangzhou Baiyunshan Pharmaceutical Holdings Co (FRA:GU5), the current Forward Dividend Yield % is 6.79% as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Guangzhou Baiyunshan Pharmaceutical Holdings Co (FRA:GU5) Overvalued in 2026?
Based on GuruFocus' analysis, Guangzhou Baiyunshan Pharmaceutical Holdings Co stock appears to be undervalued.
The current stock price of €1.55 is trading 32.6% below its estimated GF Value™ of €2.30.
GuruFocus considers Guangzhou Baiyunshan Pharmaceutical Holdings Co to be Significantly Undervalued.
Key valuation signals for FRA:GU5:
Forward Dividend Yield %: 6.79%
GF Value™: €2.30 vs. price of €1.55 (32.6% below fair value)
Industry Position: 129.4% above the Medical Distribution median (#24 of 68)
No single metric tells the full story. See the FRA:GU5 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Guangzhou Baiyunshan Pharmaceutical Holdings Co Business Description
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd is engaged in the pharmaceutical and healthcare industry, focusing on the development of a full industrial chain covering research, manufacturing, and distribution. The group operates through five reportable segments. The Modern Chinese Medicine segment involves the R&D, manufacturing, and sale of proprietary Chinese and natural medicines. The Chemical Pharmaceutical Technology segment focuses on chemical drugs, APIs, and intermediates. The Natural Beverages segment produces and sells health-oriented beverage products. The Pharmaceutical Commerce segment is engaged in the wholesale, retail, and import/export of medicines and medical devices. The Other Segments include biotechnology innovation, consumer health, and medical services.
71GF Score
Get the complete analysis for FRA:GU5
Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:GU5 has been successfully added to your 